Riskpilot← Back to searchSign inGet full accessRunMedic AB
ABActiveOrg 5593260523Erstagatan 1 C Lgh 1403General medical practice activities · NACE 8621Est. 20211 employees
Revenue 2024
SEK 89K
-49% vs 2023
EBITDA margin
0.5%
-99% vs 2023
Equity ratio
95.3%
Financial strength
Net profit 2024
SEK -25K
-149% vs 2023
| Revenue | SEK 89K | -49% |
| EBITDA | SEK 489 | -99% |
| Net profit | SEK -25K | -149% |
| Total assets | SEK 119K | -34% |
| Equity | SEK 113K | -18% |
| Employees | 1 | — |
Legal name
RunMedic AB
Org number
5593260523
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 juli 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget skall syssla med medicin- och hälsorelaterade uppdrag inom privat och allmän vårdsektor samt konsultation, rådgivning och utförande av vård, inklusive medicinska och estetiska injektioner. Företaget kommer att erbjuda konsultation kring hälsa och välmående, inkluderande skönhet, estetisk verksamhet, träning, kost och mental rådgivning. Företaget kommer också att utveckla produkter och erbjuda paketering av varor och tjänster inom dessa områden.
Address
Erstagatan 1 C Lgh 1403
Email
camilla@runfors.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 206 | 175 | 89 |
| Staff expenses | −14 | −0 | — |
| EBITDA | 85 | 82 | 0 |
| Depreciation & amort. | −8 | −17 | −25 |
| EBIT | 78 | 65 | −25 |
| Net financials | −0 | — | −1 |
| Profit before tax | 77 | 65 | −25 |
| Tax | −16 | −14 | — |
| Net profit | 62 | 52 | −25 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 113 | 181 | 119 |
| Equity | 87 | 138 | 113 |
| Long-term debt | — | — | — |
| Short-term debt | 27 | 43 | 6 |
| Total debt | 27 | 43 | 6 |
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
20222024
Equity ratio
95.3%
This company
38.2%
Market median
+149% vs market
20222024
Return on equity
-22.2%
This company
18.4%
Market median
-221% vs market
20222024
Net profit margin
-28.1%
This company
8.1%
Market median
-447% vs market
20222024
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20222024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20222024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RunMedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Cecilia Elisabeth Runfors | Chairman | 0 companies |
| Robert Emanuel Runfors | Board of Directors | 0 companies |
| Sven Erik Elof Gustafsson | Deputy Board Member | 0 companies |